Is SNAP Technology Accurate in the Diagnosis of Obstructive Sleep Apnea?
To the Editor:
Dr. Kehoe's letter (April 2005) 1 identified serious methodological shortcomings in the study by Liesching et al 2 (March 2004) and shed significant doubt on the conclusions of the study. Dr. Millman Second, Millman claimed that the initial continuous positive airway pressure derived from the clinically proven Miljeteig-Hoffstein method and reported by SNAP testing differed from the titration pressure that had been determined in his laboratory. This difference was never mentioned in his article; nor were data supporting his claim mentioned when the article was submitted for peer review. In contrast, the Miljeteig-Hoffstein formula has been well-validated. 5, 6 Finally, in his latest reply, Millman admitted systematically excluding patients who had been found to be nonapneic by the SNAP test. Why was this not fully disclosed in the article? Eliminating nonapneic patients as well as four patients with obviously severe disease (who excluded due to a split-night polysomnography study) weighted the sample heavily toward patients with mild apnea, introducing a substantial bias given the higher night-to-night variability in that group of patients. Dr. Gil Raviv has faulted us for stating that our article 1 was the first published article about SNAP technology. In fact, it was the first article about SNAP and came out prior to the publication of the University of Chicago study that appeared in Otolaryngology Head and Neck Surgery in 2004. 2 We originally submitted our publication for consideration in CHEST on October 9, 2002, and the revision was accepted September 30, 2003. In addition, our article came out in early 2004, before the University of Chicago publication. We, therefore, had no knowledge about this study. At the time of our study, there were no peer-reviewed published articles about SNAP technology. In fact, Dr. Thomas Kehoe's letter 3 notes that, prior to the publication of the University of Chicago study, there were five separate validation studies performed on SNAP, but none of them were published. He even implied 3 that there was a conspiracy to keep these studies from being published: "Previous attempts to publish these side-by-side blind studies have met with strong resistance by journals with review committees dominated by sleep specialists."
I have no objections to any type of type 3 recording device, as long as it has gone through rigorous peer review. As I mentioned in my previous letter to the editor, 4 I feel there is a potential role for portable studies in select patients with a high pretest clinical suspicion for sleep apnea.
In regard to another comment by Dr. Raviv, he noted that we systemically excluded patients that were found to be nonapneic by SNAP testing. We did not exclude these patients on purpose. They simply were not referred to us. The primary care physicians who used SNAP technology were told by the SNAP sales force that a negative study was indeed negative. The physicians, therefore, did not refer patients with a negative study to us. This does not mean that the patients did not have sleep apnea. In fact, studies 5, 6 have shown that a negative sleep evaluation should be repeated, even if the initial evaluation was standard polysomnography, if there is a high suspicion for sleep apnea. Although there are deficiencies in our study, we had no other peer-reviewed data available to us at that time.
